IS IT FEASIBLE TO WITHDRAW IMMUNOSUPPRESSIVE TREATMENT IN REAL-LIFE PATIENTS WITH ANCA-ASSOCIATED VASCULITIS?

被引：0
|
作者：
Monti, S. [1 ,2 ]
Vitolo, B. [1 ]
Balduzzi, S. [1 ]
Felicetti, M. [3 ]
Padoan, R. [3 ]
Berti, A. [4 ]
Bond, M. [5 ]
Quartuccio, L. [5 ]
Paolazzi, G. [4 ]
Schiavon, F. [3 ]
Montecucco, C. [1 ]
Caporali, R. [1 ]
机构：
[1] IRCCS Policlin S Matteo Fdn, Rheumatol, Pavia, Italy
[2] Univ Pavia, PhD Expt Med, Pavia, Italy
[3] Univ Padua, Rheumatol, Padua, Italy
[4] Santa Chiara Hosp, Rheumatol, Trento, Italy
[5] Univ Hosp S Maria della Misericordia, Rheumatol, Udine, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.4838
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0700
引用
收藏
页码：1491 / 1491
页数：1
相关论文
共 50 条
  • [21] Update on the Treatment of ANCA-associated Vasculitis
    Holle, Julia U.
    Moosig, Frank
    AKTUELLE RHEUMATOLOGIE, 2019, 44 (04) : 276 - 283
  • [22] Treatment Strategies in ANCA-Associated Vasculitis
    Nkechinyere Emejuaiwe
    Current Rheumatology Reports, 2019, 21
  • [23] Treatment of ANCA-associated vasculitis - Reply
    Bosch, Xavier
    Guilabert, Antonio
    Espinosa, Gerard
    Mirapeix, Eduard
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (23): : 2740 - 2740
  • [24] Update on treatment of ANCA-associated vasculitis
    Holle, Julia U.
    Moosig, Frank
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2024, 83 (10): : 787 - 799
  • [25] Treatment of ANCA-associated systemic vasculitis
    Fernandez de Larrinoa, Inigo Rua-Figueroa
    Erausquin Arruabarrena, Celia
    REUMATOLOGIA CLINICA, 2010, 6 (03): : 161 - 172
  • [26] Progress in treatment of ANCA-associated vasculitis
    Smith, Rona M.
    Jones, Rachel B.
    Jayne, David R. W.
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (02)
  • [27] Rituximab treatment of ANCA-associated vasculitis
    Raffray, Loic
    Guillevin, Loic
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (08) : 899 - 910
  • [28] Diagnosis and treatment of ANCA-associated vasculitis
    Holle, J. U.
    Kubacki, T.
    Aries, P.
    Hellmich, B.
    Kernder, A.
    Kneitz, C.
    Lamprecht, P.
    Schirmer, J. H.
    Schreiber, A.
    Berlit, P.
    Bley, T. A.
    Bloedt, S.
    Decker, L.
    de Groot, K.
    Engel, S.
    Jordans, I.
    Frye, B.
    Haubitz, M.
    Holl-Ulrich, K.
    Koetter, I.
    Laudien, M.
    Milger-Kneidinger, K.
    Muche-Borowski, C.
    Mueller-Ladner, U.
    Ness, T.
    Noelle, B.
    Reinhold-Keller, E.
    Ruffer, N.
    Scheuermann, K.
    Venhoff, N.
    von Vietinghoff, S.
    Wiech, T.
    Zaenker, M.
    Moosig, F.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2025, 84 (03): : 225 - 251
  • [29] Treatment of ANCA-associated Systemic Vasculitis
    Belmont, H. Michael
    BULLETIN OF THE HOSPITAL FOR JOINT DISEASES, 2006, 64 (1-2): : 60 - 66
  • [30] Avacopan for the Treatment of ANCA-Associated Vasculitis
    Jayne, David R. W.
    Merkel, Peter A.
    Schall, Thomas J.
    Bekker, Pirow
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (07): : 599 - 609
12345